|
Apr 5
|
Ligand Pharmaceuticals (LGND) Stock Dips While Market Gains: Key Facts
|
|
Apr 4
|
Gritstone (GRTS) Plummets 58% in a Week: Here's Why
|
|
Apr 4
|
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
|
|
Apr 4
|
Wall Street Analysts Think Ligand (LGND) Is a Good Investment: Is It?
|
|
Apr 4
|
Investors Heavily Search Ligand Pharmaceuticals Incorporated (LGND): Here is What You Need to Know
|
|
Apr 3
|
EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia
|
|
Apr 3
|
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
|
|
Apr 1
|
Ligand Pharmaceuticals (LGND) Ascends While Market Falls: Some Facts to Note
|
|
Mar 28
|
Ligand (LGND) Down 15.5% Since Last Earnings Report: Can It Rebound?
|
|
Mar 26
|
Ligand Pharmaceuticals (LGND) Falls More Steeply Than Broader Market: What Investors Need to Know
|
|
Mar 21
|
Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending Stock
|
|
Mar 20
|
Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider
|
|
Mar 19
|
Ligand (LGND) Is Considered a Good Investment by Brokers: Is That True?
|
|
Mar 14
|
Ligand Pharmaceuticals (LGND) Declines More Than Market: Some Information for Investors
|
|
Mar 8
|
Ligand Pharmaceuticals (LGND) Gains As Market Dips: What You Should Know
|
|
Mar 7
|
Is Trending Stock Ligand Pharmaceuticals Incorporated (LGND) a Buy Now?
|
|
Mar 5
|
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
|
|
Feb 5
|
Ligand Pharmaceuticals (LGND) Advances While Market Declines: Some Information for Investors
|
|
Feb 1
|
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Jan 11
|
Ligand Pharmaceuticals (LGND) Suffers a Larger Drop Than the General Market: Key Insights
|